MRC CTU at UCL

UKCRC Registered Clinical Trials Unit

The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.

We are committed to strengthening and expanding the evidence base for healthcare nationally and internationally.

The MRC CTU at UCL develops methodology to improve the design, conduct and analysis of clinical studies, and hosts one of the MRC’s six regional Hubs for Trials Methodology Research.

The MRC CTU at UCL is a UKCRC registered trials unit.

 

Read more about the Unit

Series of short films about clinical trials

Clinical trials are essential to finding out whether new healthcare interventions (such as new drugs) work. We have produced a series of short films, exploring:

  • What are randomised controlled trials and why are they important?
  • What is the MRC Clinical Trials Unit, and what does it do?
  • Where do ideas for trials come from?

and much more...

CASCADE study suggests HIV has increased in virulence and transmissibility
Results from the CASCADE project strongly suggest that HIV has increased in virulence and transmissibility, at least in Europe, since the virus came to light at the end of the 1970s. This research was published in the Lancet HIV in November 2014.

Read more